CUECue Biopharma, Inc.vs its industry peers
A metric-by-metric comparison of Cue Biopharma, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CUE본 종목 | $272M#8 | — | 117.9x#13 | 9.9x#6 | 195.7%#2 | 34.6%#3 | -96.7%#5 | -1151.6%#14 | — | — | — | — |
| QTTB | $327M#1 | 3.5x#1 | 3.1x#8 | 6.1x#4 | — | 162.5%#1 | 31.5%#1 | 28.1%#1 | — | — | — | — |
| ABEO | $309M#3 | — | 2.4x#7 | 53.1x#9 | — | -211.7%#13 | -1536.9%#11 | -55.6%#8 | -121.6%#1 | — | — | — |
| VNDA | $307M#4 | — | 1.4x#6 | 1.4x#2 | 8.7%#7 | -1066.7%#16 | -70.0%#4 | -100.1%#10 | — | — | — | — |
| CTNM | $311M#2 | — | 1.3x#5 | — | -100.0%#12 | -41.9%#10 | — | -25.0%#5 | — | — | 8.9%#6 | — |
| UPB | $291M#5 | — | 1.1x#2 | 102.1x#11 | 20.4%#6 | -128.4%#12 | -5618.8%#12 | -52.9%#7 | — | — | -66.8%#10 | — |
| FULC | $289M#6 | — | 0.9x#1 | — | -100.0%#12 | -670.0%#15 | — | -24.1%#4 | — | — | -48.3%#9 | — |
| PYXS | $280M#7 | — | 24.5x#11 | 20.2x#8 | -14.2%#9 | -3.0%#6 | -609.2%#8 | -696.0%#13 | — | — | 52.0%#4 | — |
| TRDA | $267M#9 | — | 1.1x#4 | 10.5x#7 | -87.9%#11 | -319.0%#14 | -621.1%#9 | -61.6%#9 | — | — | 34.6%#5 | — |
| BCYC | — | — | — | — | 105.8%#3 | -29.5%#9 | -340.4%#7 | -42.9%#6 | -794.1%#2 | — | -46.3%#8 | — |
| LYEL | $260M#11 | — | 1.1x#3 | 7229.0x#12 | -41.0%#10 | 20.0%#4 | -748344.4%#13 | -117.4%#11 | — | — | — | — |
| CAMP | $258M#12 | — | — | 73.7x#10 | 436.5%#1 | -55.2%#11 | -1502.4%#10 | — | — | — | 58.4%#2 | — |
| GLSI | $261M#10 | — | 83.7x#12 | — | — | -11.2%#7 | — | -621.1%#12 | — | — | 57.1%#3 | — |
| MGNX | $258M#13 | — | 6.0x#9 | 1.7x#3 | -0.3%#8 | -11.4%#8 | -48.7%#3 | -0.2%#2 | — | — | 162.7%#1 | — |
| FHTX | $248M#14 | — | — | 8.0x#5 | 36.8%#5 | 14.2%#5 | -279.5%#6 | — | — | — | -14.2%#7 | — |
| AKBA | $242M#15 | — | 9.7x#10 | 1.0x#1 | 47.5%#4 | 92.4%#2 | 9.9%#2 | -21.2%#3 | — | — | -68.8%#11 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice